Zurich Cantonal Bank
TEVA icon

Zurich Cantonal Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Zurich Cantonal Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5M Buy
694,126
+99,094
+17% +$3.3M 0.05% 315
2026
Q1 		$17.9M Buy
595,032
+9,346
+2% +$301K 0.04% 370
2025
Q4 		$18.3M Buy
585,686
+17,822
+3% +$439K 0.04% 364
2025
Q3 		$11.5M Buy
567,864
+35,917
+7% +$631K 0.03% 440
2025
Q2 		$8.92M Buy
531,947
+19,498
+4% +$315K 0.02% 482
2025
Q1 		$7.88M Buy
512,449
+36,843
+8% +$658K 0.02% 488
2024
Q4 		$10.5M Buy
475,606
+22,355
+5% +$407K 0.03% 430
2024
Q3 		$8.17M Buy
453,251
+14,372
+3% +$252K 0.02% 468
2024
Q2 		$7.13M Buy
438,879
+12,338
+3% +$190K 0.02% 473
2024
Q1 		$6.02M Buy
426,541
+2,261
+0.5% +$28.5K 0.02% 507
2023
Q4 		$4.43M Buy
424,280
+12,003
+3% +$112K 0.02% 559
2023
Q3 		$4.21M Buy
412,277
+34,623
+9% +$322K 0.02% 545
2023
Q2 		$2.84M Buy
377,654
+328
+0.1% +$2.66K 0.01% 632
2023
Q1 		$3.34M Buy
377,326
+17,151
+5% +$170K 0.02% 584
2022
Q4 		$3.28M Sell
360,175
-82,128
-19% -$717K 0.02% 563
2022
Q3 		$3.57M Buy
442,303
+95,814
+28% +$847K 0.02% 543
2022
Q2 		$2.61M Sell
346,489
-31,461
-8% -$274K 0.02% 620
2022
Q1 		$3.55M Buy
377,950
+3,545
+0.9% +$29.6K 0.02% 594
2021
Q4 		$3M Buy
374,405
+41,730
+13% +$377K 0.01% 645
2021
Q3 		$3.24M Buy
332,675
+35,269
+12% +$330K 0.02% 634
2021
Q2 		$2.94M Buy
297,406
+11,380
+4% +$120K 0.02% 629
2021
Q1 		$3.3M Buy
286,026
+37,046
+15% +$425K 0.02% 583
2020
Q4 		$2.4M Buy
248,980
+12,034
+5% +$115K 0.01% 689
2020
Q3 		$2.13M Buy
236,946
+40,375
+21% +$427K 0.02% 677
2020
Q2 		$2.42M Sell
196,571
-62,652
-24% -$709K 0.02% 581
2020
Q1 		$2.33M Sell
259,223
-312
-0.1% -$3.2K 0.02% 565
2019
Q4 		$2.54M Sell
259,535
-67,954
-21% -$607K 0.02% 615
2019
Q3 		$2.25M Buy
327,489
+23,000
+8% +$176K 0.02% 630
2019
Q2 		$2.81M Buy
304,489
+66,515
+28% +$802K 0.02% 560
2019
Q1 		$3.73M Sell
237,974
-65,627
-22% -$1.16M 0.03% 477
2018
Q4 		$4.68M Buy
303,601
+32,916
+12% +$675K 0.05% 390
2018
Q3 		$5.83M Sell
270,685
-4,708
-2% -$109K 0.05% 386
2018
Q2 		$6.7M Buy
275,393
+59,101
+27% +$1.21M 0.06% 351
2018
Q1 		$3.7M Buy
216,292
+18,114
+9% +$354K 0.03% 484
2017
Q4 		$3.75M Buy
198,178
+3,100
+2% +$46.6K 0.03% 475
2017
Q3 		$3.43M Sell
195,078
-24,315
-11% -$547K 0.03% 484
2017
Q2 		$7.29M Hold
219,393
– – 0.07% 301
2017
Q1 		$7.04M Buy
219,393
+2,534
+1% +$86.5K 0.07% 310
2016
Q4 		$7.86M Buy
216,859
+198,338
+1,071% +$7.92M 0.08% 267
2016
Q3 		$852K Hold
18,521
– – 0.01% 800
2016
Q2 		$930K Hold
18,521
– – 0.01% 707
2016
Q1 		$991K Hold
18,521
– – 0.01% 710
2015
Q4 		$1.22M Sell
18,521
-394
-2% -$24.3K 0.02% 659
2015
Q3 		$1.07M Buy
18,915
+18,410
+3,646% +$1.19M 0.02% 689
2015
Q2 		$30K Sell
505
-38,826
-99% -$2.4M ﹤0.01% 1038
2015
Q1 		$2.45M Sell
39,331
-225
-0.6% -$13.1K 0.03% 468
2014
Q4 		$2.27M Sell
39,556
-449
-1% -$25K 0.07% 340
2014
Q3 		$2.15M Sell
40,005
-152,000
-79% -$8.05M 0.07% 331
2014
Q2 		$10.1M Buy
192,005
+9,788
+5% +$500K 0.3% 75
2014
Q1 		$9.63M Buy
182,217
+180,979
+14,619% +$8.36M 0.3% 69
2013
Q4 		$50K Buy
+1,238
New +$48.7K ﹤0.01% 856

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Zurich Cantonal Bank's TEVA Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Teva Pharmaceuticals (TEVA) stake by 17% in Q2 2026, buying an estimated $3.3M and bringing the position to 694,126 shares worth $23.5M. The position accounts for 0.05% of the portfolio, ranked #315.

Zurich Cantonal Bank first reported a position in TEVA in Q4 2013 and has held it in 51 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Zurich Cantonal Bank held 694,126 shares of Teva Pharmaceuticals worth $23.5M as of Q2 2026.
  • Zurich Cantonal Bank bought 99,094 Teva Pharmaceuticals shares in Q2 2026, an estimated $3.3M.
  • Teva Pharmaceuticals made up 0.05% of Zurich Cantonal Bank's portfolio in Q2 2026, its #315 holding.
  • Zurich Cantonal Bank first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 51 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.